The human DEK oncogene regulates DNA damage response signaling and repair

Nucleic Acids Research

Volumn 39, Issue 17, 2011, Pages 7465-7476

  Kavanaugh, Gina M ^a   Wise Draper, Trisha M ^a   Morreale, Richard J ^a   Morrison, Monique A ^a   Gole, Boris ^a,b   Schwemberger, Sandy ^c   Tichy, Elisia D ^d   Lu, Lu ^a   Babcock, George F ^c,d   Wells, James M ^a   Drissi, Rachid ^a   Bissler, John J ^a   Stambrook, Peter J ^d   Andreassen, Paul R ^a   Wiesmüller, Lisa ^b   Wells, Susanne I ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF ULM   (Germany)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA;

ARTICLE; CONTROLLED STUDY; DEK GENE; DNA DAMAGE; DNA REPAIR; FIBROBLAST CULTURE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SENSITIVITY ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; UBIQUITINATION;

ANIMALS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; FEMALE; HUMANS; MICE; MICE, KNOCKOUT; MICE, NUDE; ONCOGENE PROTEINS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 80053180371     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr454     Document Type: Article

References (50)

1. von Lindern, M., Breems, D., van Baal, S., Adriaansen, H. and Grosveld, G. (1992) Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia. Genes Chromosomes Cancer, 5, 227-234.
2. Carro, M.S., Spiga, F.M., Quarto, M., Di Ninni, V., Volorio, S., Alcalay, M. and Muller, H. (2006) DEK Expression is controlled by E2F and deregulated in diverse tumor types. Cell Cycle, 5, 1202-1207. (Pubitemid 43845381)
3. Casas, S., Nagy, B., Elonen, E., Aventin, A., Larramendy, M.L., Sierra, J., Ruutu, T. and Knuutila, S. (2003) Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia. Leuk. Lymphoma, 44, 1935-1941. (Pubitemid 37369627)
4. Evans, A.J., Gallie, B.L., Jewett, M.A., Pond, G.R., Vandezande, K., Underwood, J., Fradet, Y., Lim, G., Marrano, P., Zielenska, M. et al. (2004) Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction. Am. J. Pathol., 164, 285-293. (Pubitemid 38364612)
5. Kondoh, N., Wakatsuki, T., Ryo, A., Hada, A., Aihara, T., Horiuchi, S., Goseki, N., Matsubara, O., Takenaka, K., Shichita, M. et al. (1999) Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res., 59, 4990-4996. (Pubitemid 29472905)
6. Kroes, R.A., Jastrow, A., McLone, M.G., Yamamoto, H., Colley, P., Kersey, D.S., Yong, V.W., Mkrdichian, E., Cerullo, L., Leestma, J. et al. (2000) The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Lett., 156, 191-198. (Pubitemid 30394677)
7. Orlic, M., Spencer, C.E., Wang, L. and Gallie, B.L. (2006) Expression analysis of 6p22 genomic gain in retinoblastoma. Genes Chromosomes Cancer, 45, 72-82. (Pubitemid 46930863)
8. Sanchez-Carbayo, M., Socci, N.D., Lozano, J.J., Li, W., Charytonowicz, E., Belbin, T.J., Prystowsky, M.B., Ortiz, A.R., Childs, G. and Cordon-Cardo, C. (2003) Gene discovery in bladder cancer progression using cDNA microarrays. Am. J. Pathol., 163, 505-516. (Pubitemid 36909413)
9. Savli, H., Sirma, S., Nagy, B., Aktan, M., Dincol, G., Salcioglu, Z., Sarper, N. and Ozbek, U. (2004) Real-time PCR analysis of af4 and dek genes expression in acute promyelocytic leukemia t (15;17) patients. Exp. Mol. Med., 36, 279-282. (Pubitemid 38981426)
10. Wu, Q., Hoffmann, M.J., Hartmann, F.H. and Schulz, W.A. (2005) Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer. Mol. Cancer, 4, 16.
11. Wise-Draper, T.M., Morreale, R.J., Morris, T.A., Mintz-Cole, R.A., Hoskins, E.E., Balsitis, S.J., Husseinzadeh, N., Witte, D.P., Wikenheiser-Brokamp, K.A., Lambert, P.F. et al. (2009) DEK proto-oncogene expression interferes with the normal epithelial differentiation program. Am. J. Pathol., 174, 71-81.
12. Wise-Draper, T.M., Allen, H.V., Thobe, M.N., Jones, E.E., Habash, K.B., Munger, K. and Wells, S.I. (2005) The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7. J. Virol., 79, 14309-14317. (Pubitemid 41552728)
13. Johung, K., Goodwin, E.C. and DiMaio, D. (2007) Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J. Virol., 81, 2102-2116.
14. Khodadoust, M.S., Verhaegen, M., Kappes, F., Riveiro-Falkenbach, E., Cigudosa, J.C., Kim, D.S., Chinnaiyan, A.M., Markovitz, D.M. and Soengas, M.S. (2009) Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Res., 69, 6405-6413.
15. Waldmann, T., Scholten, I., Kappes, F., Hu, H.G. and Knippers, R. (2004) The DEK protein-an abundant and ubiquitous constituent of mammalian chromatin. Gene, 343, 1-9. (Pubitemid 39551025)
16. Cleary, J., Sitwala, K.V., Khodadoust, M.S., Kwok, R.P., Mor-Vaknin, N., Cebrat, M., Cole, P.A. and Markovitz, D.M. (2005) p300/CBP-associated factor drives DEK into interchromatin granule clusters. J. Biol. Chem., 280, 31760-31767. (Pubitemid 41291925)
17. Kappes, F., Damoc, C., Knippers, R., Przybylski, M., Pinna, L.A. and Gruss, C. (2004) Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK. Mol. Cell. Biol., 24, 6011-6020. (Pubitemid 38787983)
18. Kappes, F., Fahrer, J., Khodadoust, M.S., Tabbert, A., Strasser, C., Mor-Vaknin, N., Moreno-Villanueva, M., Burkle, A., Markovitz, D.M. and Ferrando-May, E. (2008) DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress. Mol. Cell. Biol., 28, 3245-3257. (Pubitemid 351657089)
19. Kappes, F., Scholten, I., Richter, N., Gruss, C. and Waldmann, T. (2004) Functional domains of the ubiquitous chromatin protein DEK. Mol. Cell. Biol., 24, 6000-6010. (Pubitemid 38787982)
20. Soares, L.M., Zanier, K., Mackereth, C., Sattler, M. and Valcarcel, J. (2006) Intron removal requires proofreading of U2AF/30 splice site recognition by DEK. Science, 312, 1961-1965. (Pubitemid 43993724)
21. Tabbert, A., Kappes, F., Knippers, R., Kellermann, J., Lottspeich, F. and Ferrando-May, E. (2006) Hypophosphorylation of the architectural chromatin protein DEK in death-receptor-induced apoptosis revealed by the isotope coded protein label proteomic platform. Proteomics, 6, 5758-5772. (Pubitemid 44764013)
22. Thomas, J.O. (2001) HMG1 and 2: architectural DNA-binding proteins. Biochem. Soc. Trans., 29, 395-401.
23. Thomas, J.O. and Travers, A.A. (2001) HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem. Sci., 26, 167-174. (Pubitemid 32197576)
24. Waldmann, T., Baack, M., Richter, N. and Gruss, C. (2003) Structure-specific binding of the proto-oncogene protein DEK to DNA. Nucleic Acids Res., 31, 7003-7010. (Pubitemid 37508807)
25. Alexiadis, V., Waldmann, T., Andersen, J., Mann, M., Knippers, R. and Gruss, C. (2000) The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner. Genes Dev., 14, 1308-1312. (Pubitemid 30397074)
26. Campillos, M., Garcia, M.A., Valdivieso, F. and Vazquez, J. (2003) Transcriptional activation by AP-2alpha is modulated by the oncogene DEK. Nucleic Acids Res., 31, 1571-1575. (Pubitemid 36304919)
27. Fu, G.K., Grosveld, G. and Markovitz, D.M. (1997) DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer. Proc. Natl Acad. Sci. USA, 94, 1811-1815. (Pubitemid 27113918)
28. Gamble, M.J. and Fisher, R.P. (2007) SET and PARP1 remove DEK from chromatin to permit access by the transcription machinery. Nat. Struct. Mol. Biol., 14, 548-555. (Pubitemid 46871811)
29. Hollenbach, A.D., McPherson, C.J., Mientjes, E.J., Iyengar, R. and Grosveld, G. (2002) Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J. Cell Sci., 115, 3319-3330. (Pubitemid 34960184)
30. Sammons, M., Wan, S.S., Vogel, N.L., Mientjes, E.J., Grosveld, G. and Ashburner, B.P. (2006) Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene. J. Biol. Chem., 281, 26802-26812. (Pubitemid 44401709)
31. Hu, H.G., Scholten, I., Gruss, C. and Knippers, R. (2007) The distribution of the DEK protein in mammalian chromatin. Biochem. Biophys. Res. Commun., 358, 1008-1014. (Pubitemid 46828989)
32. Ko, S.I., Lee, I.S., Kim, J.Y., Kim, S.M., Kim, D.W., Lee, K.S., Woo, K.M., Baek, J.H., Choo, J.K. and Seo, S.B. (2006) Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK. FEBS Lett., 580, 3217-3222.
33. McGarvey, T., Rosonina, E., McCracken, S., Li, Q., Arnaout, R., Mientjes, E., Nickerson, J.A., Awrey, D., Greenblatt, J., Grosveld, G. et al. (2000) The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes. J. Cell. Biol., 150, 309-320. (Pubitemid 30491355)
34. Suwatsubashi, S., Murata, T., Lim, J., Fujiki, R., Ito, S., Suzuki, E., Tanabe, M., Zhao, Y., Kimura, S., Fujiyama, S. et al. (2010) A histone chaperone, DEK, transcriptionally coactivates a nuclear receptor. Genes Dev., 24, 159-170.
35. Meyn, M.S., Lu-Kuo, J.M. and Herzing, L.B. (1993) Expression cloning of multiple human cDNAs that complement the phenotypic defects of ataxia-telangiectasia group D fibroblasts. Am. J. Hum. Genet., 53, 1206-1216. (Pubitemid 23346219)
36. Kastan, M.B. and Bartek, J. (2004) Cell-cycle checkpoints and cancer. Nature, 432, 316-323. (Pubitemid 39551659)
37. Bakkenist, C.J. and Kastan, M.B. (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature, 421, 499-506. (Pubitemid 36168436)
38. McVey, M. and Lee, S.E. (2008) MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends Genet., 24, 529-538.
39. Wise-Draper, T.M., Mintz-Cole, R.A., Morris, T.A., Simpson, D.S., Wikenheiser-Brokamp, K.A., Currier, M.A., Cripe, T.P., Grosveld, G.C. and Wells, S.I. (2009) Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo. Cancer Res., 69, 1792-1799.
40. Wise-Draper, T.M., Allen, H.V., Jones, E.E., Habash, K.B., Matsuo, H. and Wells, S.I. (2006) Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions. Mol. Cell. Biol., 26, 7506-7519. (Pubitemid 44547701)
41. Drouet, J., Delteil, C., Lefrancois, J., Concannon, P., Salles, B. and Calsou, P. (2005) DNA-dependent protein kinase and XRCC4-DNA ligase IV mobilization in the cell in response to DNA double strand breaks. J. Biol. Chem., 280, 7060-7069. (Pubitemid 40341262)
42. Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
43. Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E.E., Linskens, M., Rubelj, I., Pereira-Smith, O. et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA, 92, 9363-9367.
44. Seluanov, A., Mittelman, D., Pereira-Smith, O.M., Wilson, J.H. and Gorbunova, V. (2004) DNA end joining becomes less efficient and more error-prone during cellular senescence. Proc. Natl Acad. Sci. USA, 101, 7624-7629. (Pubitemid 38658079)
45. Bohringer, M. and Wiesmuller, L. (2010) Fluorescence-based quantification of pathway-specific DNA double-strand break repair activities: a powerful method for the analysis of genome destabilizing mechanisms. Subcell. Biochem., 50, 297-306.
46. Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S. and Campisi, J. (2003) Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell. Biol., 5, 741-747. (Pubitemid 36986782)
47. Kim, D.W., Chae, J.I., Kim, J.Y., Pak, J.H., Koo, D.B., Bahk, Y.Y. and Seo, S.B. (2009) Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK. J. Cell. Biochem., 106, 1048-1059.
48. Secchiero, P., Voltan, R., di Iasio, M.G., Melloni, E., Tiribelli, M. and Zauli, G. (2010) The oncogene DEK promotes leukemic cell survival and is downregulated by both Nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells. Clin. Cancer Res., 16, 1824-1833.
49. Cui, X., Yu, Y., Gupta, S., Cho, Y.-M., Lees-Miller, S.P. and Meek, K. (2005) Autophosphorylation of DNA-dependent protein kinase regulates DNA end processing and may also alter double-strand break repair pathway choice. Mol. Cell. Biol., 25, 10842-10852. (Pubitemid 41747129)
50. Shrivastav, M., De Haro, L.P. and Nickoloff, J.A. (2008) Regulation of DNA double-strand break repair pathway choice. Cell Res., 18, 134-147.